ReviewFrontiers in cardiovascular medicine2024

A comprehensive review of finerenone-a third-generation non-steroidal mineralocorticoid receptor antagonist.

Shuhui Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.